Comparative Study of the Effects of Chamomile (<i>Matricaria Chamomilla </i>L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trial

AuthorMarya Kabirien
AuthorMohammad Kamalinejaden
AuthorSoodabeh Bioosen
AuthorMamak Shariaten
AuthorFarnaz Sohrabvanden
Issued Date2019-07-31en
AbstractChamomile is a fascinating plant quoted in several traditional medicine texts, which has broad-spectrum pharmacological activity and medicinal uses. The aim of this study was to assess the efficacy of chamomile syrup in reducing serum prolactin in women with idiopathic hyperprolactinemia. The study was a randomized, controlled clinical trial that was conducted on 56 women with idiopathic hyperprolactinemia for a study period of four weeks. Patients were randomly enrolled in two parallel arms and were treated by chamomile syrup at a dose of 5 mL twice daily or cabergoline tablet orally at a dose of 0.25 mg twice weekly. Serum prolactin levels were measured at baseline and the end of the 4-week study period. Any report of adverse events was also recorded. Results revealed that within the cabergoline group the reduction in the mean prolactin level was significantly greater than that of the chamomile group (pen
DOIhttps://doi.org/10.22037/ijpr.2019.1100758en
KeywordHyperprolactinemiaen
KeywordMatricaria chamomillaen
KeywordCabergolineen
KeywordProlactinen
KeywordComplementary medicineen
KeywordChamomileen
PublisherBrieflandsen
TitleComparative Study of the Effects of Chamomile (<i>Matricaria Chamomilla </i>L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trialen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-18-1612.pdf
Size:
600.12 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF